These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33986036)

  • 1. Antinociceptive Profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a Novel Orally Active
    Fotio Y; Sasso O; Ciccocioppo R; Piomelli D
    J Pharmacol Exp Ther; 2021 Aug; 378(2):70-76. PubMed ID: 33986036
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
    Fotio Y; Ciccocioppo R; Piomelli D
    Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
    Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
    Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antinociceptive effects of concomitant NAAA and peripheral FAAH inhibition.
    Mabou Tagne A; Fotio Y; Uppal PS; Piomelli D
    Exp Neurol; 2022 Nov; 357():114194. PubMed ID: 35932800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
    Bandiera T; Ponzano S; Piomelli D
    Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
    Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
    J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
    Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
    Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.
    Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y
    Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
    Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
    Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
    Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
    Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
    J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
    Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
    PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
    Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
    Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain.
    Petrosino S; Ahmad A; Marcolongo G; Esposito E; Allarà M; Verde R; Cuzzocrea S; Di Marzo V
    Pharmacol Res; 2015 Jan; 91():9-14. PubMed ID: 25447594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy.
    Toma W; Caillaud M; Patel NH; Tran TH; Donvito G; Roberts J; Bagdas D; Jackson A; Lichtman A; Gewirtz DA; Makriyannis A; Malamas MS; Imad Damaj M
    Eur J Pain; 2021 Jul; 25(6):1367-1380. PubMed ID: 33675555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
    Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
    Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain.
    Kiso T; Watabiki T; Sekizawa T
    Eur J Pharmacol; 2020 Aug; 881():173194. PubMed ID: 32445705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of activation of the immunoregulatory amidase NAAA.
    Gorelik A; Gebai A; Illes K; Piomelli D; Nagar B
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10032-E10040. PubMed ID: 30301806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
    Zhou P; Xiang L; Yang Y; Wu Y; Hu T; Liu X; Lin F; Xiu Y; Wu K; Lu C; Ren J; Qiu Y; Li Y
    Pharmacol Res; 2019 Jul; 145():104264. PubMed ID: 31063807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.